home / stock / cogt / cogt quote
Last: | $8.44 |
---|---|
Change Percent: | 0.0% |
Open: | $8.36 |
Close: | $8.44 |
High: | $8.54 |
Low: | $8.02 |
Volume: | 533,462 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.44 | $8.36 | $8.44 | $8.54 | $8.02 | 533,462 | 07-05-2024 |
$8.36 | $8.25 | $8.36 | $8.61 | $8.23 | 850,182 | 07-04-2024 |
$8.36 | $8.25 | $8.36 | $8.61 | $8.23 | 850,182 | 07-03-2024 |
$8.24 | $8.82 | $8.24 | $9.06 | $8.07 | 822,693 | 07-02-2024 |
$8.94 | $8.41 | $8.94 | $9.08 | $8.37 | 948,932 | 07-01-2024 |
$8.43 | $8.44 | $8.43 | $9 | $8.32 | 3,769,040 | 06-28-2024 |
$8.44 | $8.14 | $8.44 | $8.7 | $7.84 | 740,879 | 06-27-2024 |
$8.1 | $8.28 | $8.1 | $8.31 | $7.96 | 782,332 | 06-26-2024 |
$8.32 | $9 | $8.32 | $9.03 | $8.17 | 986,438 | 06-25-2024 |
$8.89 | $8.92 | $8.89 | $9.17 | $8.63 | 926,217 | 06-24-2024 |
$8.79 | $8.34 | $8.79 | $9.05 | $8.25 | 7,535,657 | 06-21-2024 |
$8.36 | $8.52 | $8.36 | $8.58 | $8.19 | 1,484,908 | 06-20-2024 |
$8.5 | $8.79 | $8.5 | $8.79 | $8.04 | 1,206,436 | 06-19-2024 |
$8.5 | $8.79 | $8.5 | $8.79 | $8.04 | 1,206,436 | 06-18-2024 |
$8.8 | $8.4 | $8.8 | $8.88 | $8.21 | 923,486 | 06-17-2024 |
$8.425 | $8.88 | $8.425 | $8.99 | $8.07 | 1,029,246 | 06-14-2024 |
$8.98 | $9.05 | $8.98 | $9.26 | $8.84 | 822,322 | 06-13-2024 |
$9.04 | $9.21 | $9.04 | $9.29 | $8.85 | 1,239,909 | 06-12-2024 |
$8.82 | $8.57 | $8.82 | $8.89 | $8.39 | 1,242,162 | 06-11-2024 |
$8.6 | $8.22 | $8.6 | $8.66 | $7.71 | 2,181,700 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cogent Biosciences Inc Com Company Name:
COGT Stock Symbol:
NASDAQ Market:
Cogent Biosciences Inc Com Website:
WALTHAM, Mass. and BOULDER, Colo., June 27, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced it has reached alignment with the U.S. Food and Drug Admin...
2024-06-26 16:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Patients treated with 100 mg bezuclastinib showed substantial reduction in their most severe symptoms and mast cell reactions Reductions were shown in all individual MS2D2 symptoms across domains and objective reduction in skin lesions corresponding with symptomatic improvement WALT...